Application of recombinant DNA technology: What is rDNA used for?

Recombinant DNA (rDNA) technology is a game-changing tool in modern biotechnology. It involves the process of combining genetic material from different organisms to create a new DNA sequence with unique characteristics. From agricultural and food applications to biotechnology and recombinant antibody production, the applications of rDNA technology affect everyone in some way.

In this blog post, we will answer the question of what is rDNA technology used for and dive into the respective application areas of recombinant DNA technology.

• Recombinant DNA in Biopharma: rDNA technology is the foundational architecture for modern biologics, enabling the precise engineering of expression vectors to produce complex therapeutic proteins.
• Addressing the Reproducibility Crisis: Successful rDNA application requires robust host cell lines. Utilizing Chinese hamster ovary cells ensures native-like post-translational modifications and critical batch-to-batch consistency.
• Accelerating Discovery: Advanced rDNA techniques now integrate with high-throughput transient expression workflows, allowing biotech companies to rapidly validate AI-designed antibody libraries and de-risk early-stage pipelines.
• Complex Formats: Modern rDNA applications extend beyond standard mAbs, facilitating the expression of heavily engineered constructs like bispecific antibodies and Fc-silenced variants.

Definition of recombinant DNA

Recombinant DNA (rDNA) is defined as a DNA molecule that has been artificially created by combining genetic material from different sources, typically from different organisms, using various laboratory techniques.

In pharmaceutical development, this process goes far beyond simple gene splicing. Specific gene sequences are identified—often via advanced computational biology—and optimized for expression. This includes codon optimization and the design of sophisticated expression vectors utilizing strong promoters. These engineered plasmids are then transfected into a mammalian host system.

While various expression systems exist, transfecting rDNA into Chinese hamster ovary cells remains the industry gold standard. This approach allows scientists to manipulate DNA sequences to overcome critical developability bottlenecks, ensuring the resulting recombinant proteins exhibit the correct folding, stability, and human-like glycosylation profiles necessary for clinical viability.

The creation of recombinant DNA has enabled the development of a wide range of applications in areas such as medicine, agriculture, and industry, including the production of genetically modified crops, biopharmaceuticals, and biofuels, among others.

Recombinant DNA technology Applications

The fields of application of recombinant DNA have evolved drastically since the discovery of recombinant DNA technology in the 1970s. Today, recombinant DNA plays a significant role for countless patients as well as in questions of how to provide sufficient food supply in developing countries and for environmental matters.

Application areas of rDNA technology:

• Food industry
• Agriculture
• Environmental use
• Medicine
• Research
• Biotechnology

Recombinant DNA technology in the food industry

Recombinant DNA is an important tool used in the food industry to improve the quality, safety, and nutritional value of food. It plays a crucial role in the production of genetically modified (GM) food, as rDNA technology allows scientists to insert, delete or modify specific genes in an organism’s DNA in a precise and controlled manner.

Recombinant DNA is also used to produce food additives and enzymes for the production of various food products. For example, the production of cheese and other dairy products can be improved through the use of recombinant DNA technology to produce enzymes that aid in the cheese-making process.

Here are 3 examples of genetically modified food:

• Golden Rice: Golden Rice is a genetically modified rice variety that has been engineered to produce beta-carotene, a precursor to vitamin A. This trait helps address vitamin A deficiency, which is a major health issue in developing countries.
• Flavr Savr tomato: The Flavr Savr tomato was the first commercially available genetically modified food. It was engineered to have a longer shelf life by reducing the activity of a gene that causes tomatoes to ripen and soften.
• Arctic apples: Arctic apples are genetically modified to resist browning when cut or bruised, which can reduce food waste and increase the shelf life of apples.

Use of rDNA in Agriculture

Recombinant DNA is useful in agriculture because it allows scientists to modify the genetic makeup of crops to improve their yield, quality, and resistance to pests and diseases.

GM crops have been developed to tolerate environmental stresses, such as drought or high salinity, which can reduce crop yields. They can also require fewer pesticide applications, which can reduce environmental damage and lower production costs.

Advantages that can be achieved with rDNA in agriculture include:

• improved crop yield
• pest resistance
• herbicide tolerance

Overall, recombinant DNA technology has contributed to increased food production and improved agricultural sustainability.

Environmental use of recombinant DNA technology

Recombinant DNA has several applications in the environment. Huge potential of recombinant DNA technology is seen in bioremediation.

This involves the use of microorganisms that are genetically modified to break down pollutants in the environment, such as oil spills and industrial waste. These microorganisms produce enzymes that break down the pollutants, which helps to clean up contaminated areas.

Another application of recombinant DNA in the environment is the genetic modification of plants. Scientists can modify plants to improve their ability to withstand environmental stresses, such as drought, salt, and extreme temperatures. This can help to increase crop yields and reduce the use of pesticides and fertilizers.

Recombinant DNA in medicine and research

Recombinant DNA has revolutionized medicine and research in many ways. For instance, it has enabled genetic engineering of various organisms for research purposes.

Furthermore, recombinant DNA technology has made it possible to sequence and analyze the human genome, leading to the discovery of new genes and the identification of genetic mutations that cause disease. This has greatly advanced our understanding of genetics and provided new targets for drug development.

One large field of application for recombinant DNA, related to medicine and research, is biotechnology – as shall be illustrated in the following chapter.

Application of rDNA in biotechnology

rDNA is a key tool in biotechnology, which involves the use of living organisms or their components to develop useful products and processes. One of the main applications of recombinant DNA in biotechnology is the production of recombinant proteins, including recombinant antibodies and their respective subtypes – from Fc-silenced abs to bispecific antibodies.

Recombinant antibodies production includes the use of recombinant DNA technology. These antibodies can be engineered to recognize specific targets, such as cancer cells, and can be produced in large quantities using recombinant DNA technology. This is why rAbs have opened several doors in the research and treatment of numerous medical conditions.

Ethical aspects of using recombinant DNA

Concerning the use of recombinant DNA, ethical aspects play a significant role. There are, for instance, concerns on the impact of of genetically modified organisms on biodiversity as well as general safety risks on the environment and human health.

Furthermore, questions like the ownership of patents related to genetic modifications are frequently discussed.

Nevertheless, recombinant DNA has proven to be a valuable tool in many fields, with the potential to improve countless lives – e. g. with regards to the therapeutic application of recombinant antibodies. This is why ethical aspects as well as the pros and cons of recombinant DNA have to be carefully evaluated in order to play out the numerous strengths of recombinant DNA.

Recombinant DNA in action – where we at evitria come in

At evitria, recombinant DNA technology is the starting point for our core mission: acting as your strategic development partner for transient recombinant antibody expression. Over the past 15 years, we have maintained an exclusive focus on transient expression in CHO cells, executing over 140,000 transfections and expressing more than 25,000 distinct antibodies.

We understand that moving from discovery to clinical scale-up carries significant translation risk. By utilizing the CHO platform from day one, we minimize this risk, ensuring your candidates behave consistently throughout the development lifecycle.

Whether you require high-throughput screening to validate AI-designed libraries or the specialized production of complex bispecific formats, our process guarantees peer-reviewed quality. We deliver custom recombinant antibodies with >95% purity and strictly controlled endotoxin levels (<1EU/mg), providing the reproducibility and data integrity your pipeline demands.